Cited by 2,222Cancer Cells and MetastasisCellular Mechanics and InteractionsLymphatic System and Diseases

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, Carl-Henrik, Rubin, Kristofer, Pietras, Kristian, Östman, Arne·2004·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents. There are a number of factors that contribute to increased IFP in the tumour, such as vessel abnormalities, fibrosis and contraction of the interstitial matrix. Lowering the tumour IFP with specific signal-transduction antagonists might be a useful approach to improving anticancer drug efficacy.

Integrity signals

Registry

Crossref · 10.1038/nrc1456

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 982

Flagged first, then by citations

Show all 78 references

Research works printed but not linked: 1

Kristensen, C. A. et al. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts. Br. J. Cancer 74, 533–536 (1996). · DOI

Sorted by citations

Items 701–800 of 1,003

Magnetically Actuated Active Deep Tumor Penetration of Deformable Large Nanocarriers for Enhanced Cancer Therapy
Zhu, Y., Song, Y., Cao, Z., Dong, L., Lü, Y., Yang, X., & Wang, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202103655 · Cited by 51
Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges
Lin, G., Zhou, J., Cheng, H., & Liu, G. (2023) · Small · doi:10.1002/smll.202207973 · Cited by 52
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Dong, X., Xia, S., Du, S., Zhu, M., Lai, X. P., Yao, S. Q., Chen, H., & Fang, C. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00702 · Cited by 53
Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography
Li, J., Jamin, Y., Boult, J. K. R., Cummings, C., Waterton, J. C., Ulloa, J. L., Sinkus, R., Bamber, J. C., & Robinson, S. P. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.76 · Cited by 51
Imaging Intratumoral Convection: Pressure-Dependent Enhancement in Chemotherapeutic Delivery to Solid Tumors
Gade, T. P. F., Buchanan, I. M., Motley, M. W., Mazaheri, Y., Spees, W. M., & Koutcher, J. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0611 · Cited by 51
Desmoplasia and chemoresistance in pancreatic cancer
Whatcott, C. J., Posner, R. G., Hoff, D. D. V., & Han, H. (2012) · Europe PMC (PubMed Central) · Cited by 50
Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization
Swetha, K. L., & Roy, A. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0578-5 · Cited by 54
Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
Bailey, P. C., & Martin, S. S. (2019) · Cells · doi:10.3390/cells8060553 · Cited by 53
Modelling the transport of fluid through heterogeneous, whole tumours in silico
Sweeney, P. W., d’Esposito, A., Walker‐Samuel, S., & Shipley, R. J. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006751 · Cited by 51
Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours
Angelis, B. D., Depalo, N., Petronella, F., Quintarelli, C., Curri, M. L., Pani, R., Calogero, A., Locatelli, F., & Sio, L. D. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02246e · Cited by 53
The development of an indirect computed tomography lymphography protocol for sentinel lymph node detection in head and neck cancer and comparison to other sentinel lymph node mapping techniques
Randall, E. K., Jones, M. D., Kraft, S. L., & Worley, D. R. (2020) · Veterinary and Comparative Oncology · doi:10.1111/vco.12585 · Cited by 51
Effects of the Vascular Disrupting Agent ZD6126 on Interstitial Fluid Pressure and Cell Survival in Tumors
Skliarenko, J., Lunt, S. J., Gordon, M. L., Vitkin, I. A., Milosevic, M., & Hill, R. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2046 · Cited by 51
Intravesical Mucoadhesive Hydrogel Induces Chemoresistant Bladder Cancer Ferroptosis through Delivering Iron Oxide Nanoparticles in a Three-Tier Strategy
Qi, A., Wang, C., Ni, S., Meng, Y., Wang, T., Yue, Z., Yang, K., Li, Y., Cheng, Z., Guo, P., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c14944 · Cited by 50
Light-triggered nitric oxide release and structure transformation of peptide for enhanced intratumoral retention and sensitized photodynamic therapy
Jiang, L., Chen, D., Jin, Z., Xia, C., Xu, Q., Fan, M., Dai, Y., Liu, J., Li, Y., & He, Q. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.035 · Cited by 50
A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies
Youden, B., Jiang, R., Carrier, A. J., Servos, M. R., & Zhang, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c06337 · Cited by 53
Fluid flow to mimic organ function in 3D in vitro models
Juste-Lanas, Y., Hervás-Raluy, S., García‐Aznar, J. M., & González‐Loyola, A. (2023) · APL Bioengineering · doi:10.1063/5.0146000 · Cited by 53
Changes in Tissue Fluidity Predict Tumor Aggressiveness In Vivo
Sauer, F., Grosser, S., Shahryari, M., Hayn, A., Guo, J., Braun, J., Briest, S., Wolf, B., Aktas, B., Horn, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202303523 · Cited by 49
Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution.
Huang, D., Lan, H., Liu, F., Wang, S., Chen, X., Jin, K., & Mou, X. (2015) · Europe PMC (PubMed Central) · Cited by 50
Chondroitin sulfate expression predicts poor outcome in breast cancer
Belting, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1164 · Cited by 50
Methodology for Quantifying Interactions Between Perfusion Evaluated by DCE-US and Hypoxia Throughout Tumor Growth
Elie, N., Kaliski, A., PERONNEAU, P., Opolon, P., Roche, A. J., & Lassau, N. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.09.011 · Cited by 50
Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment
Xiong, Y. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.253 · Cited by 51
General Overview of Radioimmunotherapy of Solid Tumors
Navarro‐Teulon, I., Lozza, C., Pèlegrin, A., Vivès, É., & Pouget, J. (2013) · Immunotherapy · doi:10.2217/imt.13.34 · Cited by 54
Amphiphilic Polyelectrolyte/Prodrug Nanoparticles Constructed by Synergetic Electrostatic and Hydrophobic Interactions with Cooperative pH-Sensitivity for Controlled Doxorubicin Delivery
Huang, P., Wang, W., Zhou, J., Zhao, F., Zhang, Y., Liu, J., Liu, J., Dong, A., Kong, D., & Zhang, J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00962 · Cited by 50
Current progress in antivascular tumor therapy
Ho, Y.-J., Wang, T.-C., Fan, C., & Yeh, C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.001 · Cited by 51
Ligand-Switchable Micellar Nanocarriers for Prolonging Circulation Time and Enhancing Targeting Efficiency
Cheng, T., Zhang, Y., Liu, J., Ding, Y., Ou, H., An, Y., An, Y., Liu, J., Liu, J., & Shi, L. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18137 · Cited by 50
Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment
Zhu, X., Li, C., Lu, Y., Liu, Y., Wan, D., Zhu, D., Pan, J., & Ma, G. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.008 · Cited by 49
Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma
Moen, I., Tronstad, K. J., Kolmannskog, O., Salvesen, G. S., Reed, R. K., & Stuhr, L. E. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-446 · Cited by 49
Bacteria-Assisted Transport of Nanomaterials to Improve Drug Delivery in Cancer Therapy
Jiménez‐Jiménez, C., Moreno, V., & Vallet‐Regí, M. (2022) · Nanomaterials · doi:10.3390/nano12020288 · Cited by 57
RETRACTED: Drug delivery based on chitosan, β-cyclodextrin and sodium carboxymethyl cellulose as well as nanocarriers for advanced leukemia treatment
Hosseini, M., Amiri, M., Ghanbari, M., Mahdi, M. A., Abdulsahib, W. K., & Salavati‐Niasari, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113369 · Cited by 50
Retracted
Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
Slika, H., Karimov, Z., Alimonti, P., Abou‐Mrad, T., Fazio, E. D., Alomari, S., & Tyler, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216316 · Cited by 52
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Luo, R., Le, H., Wu, Q., & Gong, C. (2024) · Small · doi:10.1002/smll.202312153 · Cited by 50
Matrix Metalloproteinase- and pH-Sensitive Nanoparticle System Enhances Drug Retention and Penetration in Glioblastoma
Dosta, P., Dion, M. Z., Prado, M., Hurtado, P., Javelly, C. J. R., Cryer, A. M., Soria, Y., Interiano, N. A., Taboada, G. M., & Artzi, N. (2024) · ACS Nano · doi:10.1021/acsnano.3c03409 · Cited by 50
The pharmacological point of view of resistance to therapy in tumors
Damia, G. L. M., & Garattini, S. K. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.05.008 · Cited by 48
The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3
Qin, C., He, B., Dai, W., Lin, Z., Zhang, H., Wang, X., Wang, J., Zhang, X., Wang, G., Yin, L., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.077 · Cited by 49
Design of a novel class of protein‐based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers
Xue, S., Qiao, J., Pu, F., Cameron, M., & Yang, J. J. (2013) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1205 · Cited by 49
The Fate of Nanocarriers As Nanomedicines In Vivo: Important Considerations and Biological Barriers to Overcome
Moros, M., Mitchell, S. G., Grazú, V., & de la Fuente, J. M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320220003 · Cited by 49
Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling
Shah, A. D., Bouchard, M. J., & Shieh, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142337 · Cited by 49
Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model
Khosrawipour, V., Khosrawipour, T., Falkenstein, T., Díaz-Carballo, D., FÖRSTER, E., Osma, A., Adamietz, I. U. A., Zieren, J., & Fakhrian, K. (2016) · Anticancer Research · doi:10.21873/anticanres.11008 · Cited by 50
Developments and future clinical outlook of taxane nanomedicines
Louage, B., Wever, O. D., Hennink, W. E., & Geest, B. G. D. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.027 · Cited by 50
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
Gilabert‐Oriol, R., Ryan, G. M., Leung, A. W. Y., Firmino, N. S., Bennewith, K. L., & Bally, M. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102922 · Cited by 53
Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead
Akhter, M. H., Beg, S., Tarique, M., Malik, A., Afaq, S., Choudhry, H., & Hosawi, S. B. I. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129777 · Cited by 51
pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor
Wang, X., Xu, J., Xu, X., Qin, F., & Tang, R. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111004 · Cited by 49
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
Garcia, P. E., Scales, M. K., Allen, B. L., & di Magliano, M. P. (2020) · Cells · doi:10.3390/cells9112464 · Cited by 48
Hyperthermia-triggered biomimetic bubble nanomachines
Gao, J., Qin, H., Wang, F., Liu, L., Tian, H., Wang, H., Wang, S., Ou, J., Ye, Y., Peng, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40474-9 · Cited by 50
Nucleic acid-based drugs for patients with solid tumours
Huayamares, S. G., Loughrey, D., Kim, H., Dahlman, J. E., & Sorscher, E. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00883-1 · Cited by 54
A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy
Winslow, T. B., Eranki, A., Ullas, S., Singh, A. K., Repasky, E. A., & Sen, A. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1037800 · Cited by 50
Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin‐mediated vascular‐targeting therapy
Chen, B., Crane, C., He, C., Gondek, D. C., Agharkar, P. A., Savellano, M. D., Hoopes, P. J., & Pogue, B. W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23538 · Cited by 48
Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
Chang, D.-K., Li, P., Lu, R., Jane, W., & Wu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083239 · Cited by 48
Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma
Nathan, S. S., Huvos, A. G., Casas-Ganem, J. E., Yang, R. R., Linkov, I., Sowers, R. S., DiResta, G. R., Gorlick, R. G., & Healey, J. H. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20633 · Cited by 48
Extracellularly activatable nanocarriers for drug delivery to tumors
Abouelmagd, S. A., Hyun, H., & Yeo, Y. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.930434 · Cited by 50
An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma
Xu, H., Mao, K., Lu, C., Fan, Z.-L., Yang, J., Xu, J., Chen, P.-P., Zhuge, D., Shen, B., Jin, B., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.026 · Cited by 48
Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs
van den Brand, D., Massuger, L. F. A. G., Brock, R. E., & Verdurmen, W. P. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00699 · Cited by 50
Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles
Cruz, E., & Kayser, V. (2019) · Cancers · doi:10.3390/cancers11060870 · Cited by 49
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives
Fleuren, E. D. G., Versleijen‐Jonkers, Y. M. H., Boerman, O. C., & van der Graaf, W. T. A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.005 · Cited by 47
Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment
DeWever, J., Frérart, F., Bouzin, C., Baudelet, C., Ansiaux, R., Sonveaux, P., Gallez, B., Dessy, C., & Féron, O. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060968 · Cited by 48
Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions
Sheth, R. A., Wehrenberg-Klee, E. P., Patel, S. P., Brock, K. K., Fotiadis, N., & de Baère, T. (2024) · Radiology · doi:10.1148/radiol.232654 · Cited by 51
Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine
Cassani, M., Fernandes, S., Pagliari, S., Cavalieri, F., Caruso, F., & Forte, G. (2025) · Advanced Science · doi:10.1002/advs.202409898 · Cited by 48
Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity
Wang, Y., Cheng, X., Li, X., Chen, W., Zhang, X., & Liu, Y. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104979 · Cited by 57
Cytotoxicity of Paclitaxel in Biodegradable Self-Assembled Core-Shell Poly(Lactide-Co-Glycolide Ethylene Oxide Fumarate) Nanoparticles
He, X., Ma, J., Mercado‐Pagán, Á. E., Xu, W., & Jabbari, E. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9513-z · Cited by 47
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis.
Baronzio, G., Schwartz, L. H., Kiselevsky, M. V., Guais, A., Sanders, E., Milanesi, G., Baronzio, M., & Freitas, I. (2012) · PubMed · Cited by 47
Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer
Malik, P. R. V., Phipps, C. J., Edginton, A. N., & Blay, J. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2259-3 · Cited by 48
PEGylated “stealth” nanoparticles and liposomes
Shen, Z., Fisher, A., Liu, W. K., & Li, Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00001-5 · Cited by 48
Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation
Zhang, H., Zhu, Y., & Shen, Y. (2018) · Small · doi:10.1002/smll.201800360 · Cited by 47
Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics
Stiltner, J., McCandless, K., & Zahid, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060890 · Cited by 47
Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models
Roy, S. M., Garg, V., Barman, S., Ghosh, C., Maity, A. R., & Ghosh, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.785937 · Cited by 49
Enhanced Intracellular Transcytosis of Nanoparticles by Degrading Extracellular Matrix for Deep Tissue Radiotherapy of Pancreatic Adenocarcinoma
Wang, L., Dou, J., Jiang, W., Wang, Q., Liu, Y., Liu, H., & Wang, Y. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c01005 · Cited by 47
Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
Liu, Q., Gai, Y., Chen, Y., Lan, X., & Jiang, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081226 · Cited by 48
Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?
Parakh, S., Nicolazzo, J. A., Scott, A. M., & Gan, H. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718590 · Cited by 46
Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues
Chu, B., Yang, Y., Tang, J., Song, B., He, Y., & Wang, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202208422 · Cited by 46
Nanoparticles with transformable physicochemical properties for overcoming biological barriers
Lu, Q., Yu, H., Zhao, T., Zhu, G., & Li, X. (2023) · Nanoscale · doi:10.1039/d3nr01332d · Cited by 46
Depolymerizable Enzymatic Cascade Nanoreactor for Self‐Enhancing Targeting Synergistic Tumor Therapy
Song, L., Zhao, Q., Feng, S., He, Y., Li, Y., Wang, S., & Zhang, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202414121 · Cited by 46
Biomimetic tumor microenvironment on a microfluidic platform
Ma, H., Xu, H. M., & Qin, J. (2013) · Biomicrofluidics · doi:10.1063/1.4774070 · Cited by 46
Medical Imaging Informatics
Hsu, W. W. Y., El-Saden, S. M., & Taira, R. K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1503-8_8 · Cited by 46
“NextGen” Biologics: Bispecific Antibodies and Emerging Clinical Results
Thakur, A. B., & Lum, L. G. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1150996 · Cited by 46
Evaluation of drug penetration with cationic micelles and their penetration mechanism using an in vitro tumor model
Suzuki, H., & Bae, Y. H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.037 · Cited by 46
Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress
Bahrami, A., Khazaei, M., Hassanian, S. M., Shahidsales, S., Joudi‐Mashhad, M., Maftouh, M., Jazayeri, M. H., Parizade, M. R., Ferns, G. A., & Avan, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26041 · Cited by 46
Light-enhanced hypoxia-responsive nanoparticles for deep tumor penetration and combined chemo-photodynamic therapy
Li, Z., Wu, M., Bai, H., Liu, X., & Tang, G. (2018) · Chemical Communications · doi:10.1039/c8cc08445a · Cited by 48
Osmotic Delivery and Release of Lipid-Encapsulated Molecules via Sequential Solution Exchange
Shin, S., Doan, V. S., & Feng, J. (2019) · Physical Review Applied · doi:10.1103/physrevapplied.12.024014 · Cited by 46
“Nano-lymphatic” photocatalytic water-splitting for relieving tumor interstitial fluid pressure and achieving hydrodynamic therapy
Cong, C., Rao, C., Ma, Z., Yu, M., He, Y., He, Y., Hao, Z., Li, C., Lou, H., & Gao, D. (2020) · Materials Horizons · doi:10.1039/d0mh01295e · Cited by 46
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics
Bui, K., & Hong, Y. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.597374 · Cited by 46
Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges
Li, W., Little, N., Park, J., Foster, C. A., Chen, J., & Lu, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00455 · Cited by 46
More than a scaffold: Stromal modulation of tumor immunity
Johansson, A., Hamzah, J., & Ganß, R. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.001 · Cited by 47
Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure
Gulliksrud, K., Brurberg, K. G., & Rofstad, E. K. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.08.015 · Cited by 46
Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy
Guo, J., Pan, X., Wu, Q., Li, P., Wang, C., Liu, S., Zhang, H., Huang, Z., Mou, X., Liu, H., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02217-8 · Cited by 50
Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model
Kim, S., Decarlo, L., Cho, G. Y., Jensen, J. H., Sodickson, D. K., Moy, L. P., Formenti, S. C., Schneider, R. J., Goldberg, J. D., & Sigmund, E. E. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1793 · Cited by 45
Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review)
Magadoux, L., Isambert, N., Plenchette, S., Jeannin, J., & Laurens, V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2517 · Cited by 45
Biodistribution of ultra small gadolinium-based nanoparticles as theranostic agent: Application to brain tumors
Miladi, I., Duc, G. L., Kryza, D., Berniard, A., Mowat, P., Roux, S., Taleb, J., Bonazza, P., Perriat, P., Lux, F., et al. (2012) · Journal of Biomaterials Applications · doi:10.1177/0885328212454315 · Cited by 45
Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma
Kłosowska‐Wardęga, A., Hasumi, Y., Burmakin, M., Åhgren, A., Stuhr, L. E. B., Moen, I. N., Reed, R. K., Rubin, K., Hellberg, C. B., & Heldin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008149 · Cited by 45
Self-citation
Nanoparticles for the treatment of ocular neovascularizations
Hennig, R., & Göpferich, A. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.027 · Cited by 45
Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells
Singh, S. P., Sharma, M., & Gupta, P. K. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.11.037 · Cited by 45
Radiation-induced changes in microcirculation and interstitial fluid pressure affecting the delivery of macromolecules and nanotherapeutics to tumors
Multhoff, G., & Vaupel, P. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00165 · Cited by 44
Biomechanical forces in the skeleton and their relevance to bone metastasis: Biology and engineering considerations
Lynch, M. E., & Fischbach, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.009 · Cited by 47
Therapeutic targeting of platelet-derived growth factor receptors in solid tumors
Ehnman, M., & Östman, A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.847086 · Cited by 45
Self-citation
NIR Light-Activated Drug Release for Synergetic Chemo–Photothermal Therapy
Yuan, A., Wei, H. J., Liu, X., Zhang, Z., Zhang, Y., Wu, J., & Hu, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00820 · Cited by 45
Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes
Luo, D., Geng, J., Li, N., Carter, K. A., Shao, S., Atilla‐Gokcumen, G. E., & Lovell, J. F. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0276 · Cited by 45
Optimization of siRNA delivery to target sites: issues and future directions
Khalil, I. A., Yamada, Y., & Harashima, H. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1520836 · Cited by 48
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Bennie, L. A., McCarthy, H. O., & Coulter, J. A. (2018) · Cancer Nanotechnology · doi:10.1186/s12645-018-0044-6 · Cited by 45
MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions
Patel, B., Samreen, N., Zhou, Y., Chen, J., Brandt, K. R., Ehman, R. L., & Pepin, K. M. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.08.005 · Cited by 49
Thermosensitive liposomes: a promising step toward localised chemotherapy
Chaudhry, M., Lyon, P. C., Coussios, C. C., & Carlisle, R. C. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2099834 · Cited by 45
Molecular cancer cell responses to solid compressive stress and interstitial fluid pressure
Purkayastha, P., Jaiswal, M. K., & Lele, T. P. (2021) · Cytoskeleton · doi:10.1002/cm.21680 · Cited by 45

Authors: Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A.
Affiliations: Ludwig Cancer Research (SE)
Uppsala University (SE)
University of California, San Francisco (US)
Karolinska Institutet (SE)
Corresponding author: Heldin, Carl-Henrik
ORCID: Heldin, Carl-Henrik
Rubin, Kristofer
Pietras, Kristian
Östman, Arne
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-10
Volume: 4
Issue: 10
Pages: 806-813
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1456
OpenAlex: W2028156849
Cited by: 2,222
References: 78
Citations by year: 2026: 121 · 2025: 110 · 2024: 118 · 2023: 119 · 2022: 163 · 2021: 158 · 2020: 158 · 2019: 123 · 2018: 123 · 2017: 135 · 2016: 133 · 2015: 110 · 2014: 117 · 2013: 124 · 2012: 87
FWCI: 3.19
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: Cancerfonden
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords: interstitial fluid pressure, solid tumors, tumor microenvironment, tumor fibrosis, anticancer drug delivery, tumor hypoxia
MeSH terms: Alprostadil, Animals, Antineoplastic Agents, Biological Transport, Bradykinin, Humans, Hyaluronoglucosaminidase, Hydrostatic Pressure, Neoplasms, Niacinamide, Platelet-Derived Growth Factor, Tumor Necrosis Factor-alpha, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Extracellular Fluid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks